Advertisement

Ads Placeholder
Loading...

Cellectis S.A.

CMVLFPNK
Healthcare
Biotechnology
$3.08
$-1.32(-30.00%)
U.S. Market opens in 5h 4m

Cellectis S.A. (CMVLF) Stock Overview

Explore Cellectis S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap222.8M
P/E Ratio-4.56
EPS (TTM)$-0.33
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 Month$4.56
3 Months$5.35
1 Year Target$6.14

CMVLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellectis S.A. (CMVLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 2.73, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $6.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.56 and a market capitalization of 222.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-30.00%
3-Month Change
-30.00%
6-Month Change
-27.70%
Year-to-Date (YTD) Change
-30.00%
1-Year Change
146.40%
3-Year Change
54.77%
5-Year Change
-84.53%
All-Time (Max) Change
-77.01%

Contact Information

33 1 81 69 16 00
8, rue de la Croix Jarry, Paris, NaN, 75013

Company Facts

2,160 Employees
IPO DateJul 1, 2014
CountryFR

Frequently Asked Questions